A - Human Necessities – 61 – M
Patent
A - Human Necessities
61
M
A61M 5/158 (2006.01) A61K 9/70 (2006.01) A61K 31/395 (2006.01) A61K 31/727 (2006.01) A61K 38/19 (2006.01) A61K 38/27 (2006.01) A61K 38/28 (2006.01) A61M 37/00 (2006.01) A61N 1/30 (2006.01) A61K 9/00 (2006.01)
Patent
CA 2450354
A method for administration of a substance into the dermis of a mammal is disclosed. The method involves administration into the dermis by injection which results in improved systemic absorption relative to that obtained upon subcutaneous administration of the substance. The substance administered may be a growth hormone, alow molecular weight heparin or a dopamine receptor agonist.
Procédé servant à administrer une substance dans le derme d'un mammifère. Ce procédé consiste à effectuer l'administration dans le derme par injection, ce qui permet d'obtenir une absorption systémique améliorée par rapport à une administration sous-cutanée de la substance. Cette dernière peut être une hormone de croissance, héparine de poids moléculaire bas ou un agoniste du récepteur de dopamine.
Osler Hoskin & Harcourt Llp
Pharmacia Corporation
LandOfFree
Enhanced systemic absorption of intradermally delivered... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced systemic absorption of intradermally delivered..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced systemic absorption of intradermally delivered... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2046103